Adiponectin levels decrease independently of body mass index and diabetes type after the normalization of hyperglycemia

Background/aim Acute hyperglycemia is generally a frequently encountered condition in the emergency department (ED), because it is seen as a complication of diabetes mellitus (DM). In this study, we aimed to detect the change in adiponectin levels during acute hyperglycemic states and after normalization of blood glucose with insulin treatment. Materials and methods Forty-eight patients over the age of 18 years who were admitted to the ED with acute hyperglycemia were included in the study. Serum samples were taken from patients on admission and 6 h after the normalization of blood glucose with insulin treatment, and adiponectin levels were measured in both samples. Results There were 21 female and 27 male patients with a median age of 58.7 ± 18 years. All patients’ blood glucose levels were normalized with insulin treatment according to international recommendations. Serum adiponectin levels decreased significantly after the normalization of blood glucose in the whole group. Adiponectin levels decreased from 28.9 ± 16.5 to 12.1 ± 10.9 μg/mL (P < 0.0001) in the whole group. This decrease was independent of diabetes type and body mass index. Conclusion Normalization of blood glucose in patients with hyperglycemia caused a decrease in adiponectin levels, independent of diabetes type and/or body weight in an acute emergency setting. Inhibited upregulation of adiponectin secretion and/or blunted suppressive effect of insulin due to hyperglycemia or exogenous insulin administration may have caused the decrease in adiponectin levels.

[1]  Muhammet Ozer,et al.  The Role of Adiponectin in Maintaining Metabolic Homeostasis. , 2020, Current diabetes reviews.

[2]  S. Genovesi,et al.  Adiponectin and Cardiovascular Risk. From Pathophysiology to Clinic: Focus on Children and Adolescents , 2019, International journal of molecular sciences.

[3]  S. Dhanasekaran,et al.  Emerging Role of Adipocytokines in Type 2 Diabetes as Mediators of Insulin Resistance and Cardiovascular Disease. , 2017, Canadian journal of diabetes.

[4]  R. Chowdhury,et al.  Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis , 2018, Scientific Reports.

[5]  A. F. Reis,et al.  Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review , 2017, Archives of endocrinology and metabolism.

[6]  G. Sweeney,et al.  Adiponectin improves insulin sensitivity via activation of autophagic flux. , 2017, Journal of molecular endocrinology.

[7]  S. Jain,et al.  Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction , 2017, International journal of molecular sciences.

[8]  Tina Gupta,et al.  Update on Glucose Management Among Noncritically Ill Patients Hospitalized on Medical and Surgical Wards , 2017, Journal of the Endocrine Society.

[9]  H. Marzouk,et al.  Serum adipokines and vitamin D levels in patients with type 1 diabetes mellitus , 2016, Archives of medical science : AMS.

[10]  P. Arner,et al.  Circulating and Adipose Levels of Adipokines Associated With Insulin Sensitivity in Nonobese Subjects With Type 2 Diabetes , 2016, The Journal of clinical endocrinology and metabolism.

[11]  H. Ruan,et al.  Adiponectin signaling and function in insulin target tissues , 2016, Journal of molecular cell biology.

[12]  S. Davis,et al.  Acute effects of hyperinsulinemia and hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight and obese humans. , 2015, American journal of physiology. Endocrinology and metabolism.

[13]  Christodoulos,et al.  The Effect of Glucose Loading on Adiponectin Levels in Diabetes Mellitus Type 2: Implications for Endothelial Dysfunction , 2015 .

[14]  Kunihiro Suzuki,et al.  The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes. , 2013, Translational research : the journal of laboratory and clinical medicine.

[15]  D. Yavuz,et al.  Serum adipokine levels in type 1 diabetic patients: association with carotid intima media thickness. , 2012, Metabolic syndrome and related disorders.

[16]  S. Toda,et al.  Organotypic culture of human bone marrow adipose tissue , 2010, Pathology international.

[17]  S. Jebb,et al.  Acute effects of hyperglycaemia on asymmetric dimethylarginine (ADMA), adiponectin and inflammatory markers (IL-6, hs-CRP) in overweight and obese women with metabolic syndrome , 2010, British journal of biomedical science.

[18]  K. Hara,et al.  Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus. , 2009, Metabolism: clinical and experimental.

[19]  M. Hamilton,et al.  Systemic Fate of the Adipocyte-Derived Factor Adiponectin , 2009, Diabetes.

[20]  K. Cianflone,et al.  Regulation of leptin, adiponectin and acylation-stimulating protein by hyperinsulinaemia and hyperglycaemia in vivo in healthy lean young men. , 2008, Diabetes & metabolism.

[21]  B. Wolffenbuttel,et al.  Plasma adiponectin is modestly decreased during 24‐hour insulin infusion but not after inhibition of lipolysis by Acipimox , 2005, Scandinavian journal of clinical and laboratory investigation.